Department of Pathology, University of Medicine, Pharmacy, Science and Technology "George E Palade" of Targu Mures, Targu Mures.
Departments of Pathology.
Am J Surg Pathol. 2023 Dec 1;47(12):1376-1389. doi: 10.1097/PAS.0000000000002122. Epub 2023 Sep 13.
We aimed to determine the frequency of human papillomavirus-independent (HPVI) cervical squamous cell carcinoma (SCC) and to describe clinicopathologic characteristics. Among 670 patients with surgically treated SCCs in an established multi-institutional cohort, 447 had available tissue. Tissue microarrays were constructed and studied by in situ hybridization (ISH) for high-risk and low-risk human papillomavirus (HPV) mRNA and immunohistochemistry for p16 and p53. Tumors were HPVI if negative by HPV ISH and they failed to show diffuse p16 positivity by immunohistochemistry, and human papillomavirus-associated (HPVA) if positive by HPV ISH. Ten HPVI SCCs and 435 HPVA SCCs were identified; 2 cases were equivocal and excluded from analysis. The overall rate of HPVI SCC was low (2%) but was higher among older patients (7% in patients above 60 y of age and 17% in patients above 70 y of age). Compared with HPVA, patients with HPVI SCC were significantly older (median age, 72 vs. 49, P <0.001) and diagnosed at a higher stage (40% vs. 18% with stage III/IV disease, P =0.055). p53 expression was varied; 2 cases (20%) had null expression and 8 (80%) had wild-type expression. HPVI SCCs were heterogenous, with keratinizing, nonkeratinizing, and warty morphologies observed. Several cases had a precursor lesion reminiscent of differentiated vulvar intraepithelial neoplasia, with prominent basal atypia and hypereosinophilia or a basaloid-like morphology. Two patients (20%) had distant recurrences within 12 months, and 3 (30%) died of disease during follow-up. HPVI SCCs are rare tumors that are more common among older patients with higher stage disease and have important clinical and histologic differences from HPVA SCCs.
我们旨在确定人乳头瘤病毒非依赖性(HPVI)宫颈鳞状细胞癌(SCC)的频率,并描述其临床病理特征。在一个已建立的多机构队列中,对 670 例接受手术治疗的 SCC 患者中,有 447 例有组织可用。通过原位杂交(ISH)对组织微阵列进行高风险和低风险人乳头瘤病毒(HPV)mRNA 以及 p16 和 p53 的免疫组化研究。如果 HPV ISH 为阴性且免疫组化未见弥漫性 p16 阳性,则肿瘤为 HPVI,如果 HPV ISH 为阳性,则为 HPV 相关(HPVA)。确定了 10 例 HPVI SCC 和 435 例 HPVA SCC;2 例结果不确定,被排除在分析之外。HPVI SCC 的总体发生率较低(2%),但在年龄较大的患者中较高(60 岁以上患者为 7%,70 岁以上患者为 17%)。与 HPVA 相比,HPVI SCC 患者明显年龄较大(中位年龄为 72 岁 vs. 49 岁,P<0.001),且诊断分期较高(3 期/4 期疾病患者为 40% vs. 18%,P=0.055)。p53 表达不同;2 例(20%)表达缺失,8 例(80%)表达野生型。HPVI SCC 呈异质性,观察到角化、非角化和疣状形态。一些病例具有类似于分化型外阴上皮内瘤变的前驱病变,表现为基底异型性明显、嗜酸性粒细胞增多或基底样形态。2 例(20%)患者在 12 个月内出现远处复发,3 例(30%)患者在随访期间死于疾病。HPVI SCC 是罕见的肿瘤,在年龄较大的患者中更为常见,与 HPVA SCC 相比具有重要的临床和组织学差异。